Fructose-1,6-bisphosphatase deficiency: the clinical characteristics, molecular consequences of FBP1 variants, and emerging non-canonical functions of FBP1.
Clinical features, diagnosis, genetics, and management of FBPase deficiency are summarized, with particular emphasis on the functional interpretation of FBP1 variants and the broader biological roles of FBP1.
Abstract
Fructose-1,6-bisphosphatase (FBPase) deficiency is a rare autosomal recessive disorder of gluconeogenesis caused by the biallelic pathogenic variants of FBP1. Recurrent episodes of hypoglycemia and lactic acidosis usually occur during childhood. Because the ketone levels during hypoglycemic attacks may vary in patients with FBPase deficiency, differentiation from fatty acid oxidation disorders can be challenging. A urinary organic acid analysis during hypoglycemic attacks, particularly the detection of glycerol and glycerol-3-phosphate, in conjunction with plasma acylcarnitine profiling, is useful for distinguishing between these disorders. Furthermore, targeted next-generation sequencing-based multigene panels for hypoglycemia and related inherited metabolic disorders have become increasingly valuable diagnostic tools in this field. At the molecular level, a useful working model is to interpret FBP1 variants along three functional dimensions: protein abundance/stability, catalytic activity, and non-canonical restraint of AKT signaling. Within this framework, many missense variants fall into two major classes: variants that preserve protein abundance, but impair the catalytic activity and variants that reduce both protein abundance and the catalytic activity through defective folding. Selected C-terminal variants additionally disrupt the AKT-regulatory scaffolding function. Emerging experimental evidence suggests that FBP1 influences hepatic lipid accumulation, fibrosis, and tumorigenesis through mechanisms beyond its canonical role in gluconeogenesis. This review summarizes the clinical features, diagnosis, genetics, and management of FBPase deficiency, with particular emphasis on the functional interpretation of FBP1 variants and the broader biological roles of FBP1.
Fructose-1,6-bisphosphatase (FBP) deficiency disease is a rare autosomal recessive inherited metabolic disorder. It has defects in key enzymes of the liver gluconeogenesis pathway caused by FBP1 gene mutation of Zone q22 in the chromosome 9#. Since FBP is the last step of rate-limiting enzyme of gluconeogenesis, defici...
Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is a hereditary genetic defect which is one of the most prevalent polymorphisms and enzymopathies in humans, affecting approximately 500 million people worldwide. Antimalarial medications, such as primaquine and tafenoquine, have been linked to the hemolysis in the...
Abstract: Ribose-5-Phosphate Isomerase (RPI) Deficiency is an exceptionally rare autosomal recessive genetic disorder caused by mutations in the RPIA gene (Gard, 2026). With only five known cases documented worldwide as of 2025, it is considered one of the rarest human diseases. The disorder impairs the pentose phospha...
Moukthika Palla· Advanced International Journ...· 0 citations
Background: Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency is a rare autosomal recessive inborn error of metabolism caused by biallelic mutations in the OXCT1 gene. It results in defective ketone body utilization and presents with recurrent or life-threatening episodes of high anion gap metabolic ketoacidosi...
R. Akella· Journal of Pediatric Genetic...· 0 citations
It is demonstrated that GFAT plays an important role in the hexosamine biosynthetic pathway, trophozoite proliferation, and efficient encystation in Entamoeba, and supports its further evaluation as a potential therapeutic target for amebiasis.
Ghulam Jeelani, Farida Ifadotunnikmah, Tomoyoshi Nozaki· International Journal of Bio...· 0 citations
Glycogen storage disease Ib (GSD Ib) is an ultra-rare metabolic disease caused by variants in the SLC37A4 gene affecting activity of the glucose-6-phosphate transporter (G6PT). G6PT mediates transport of glucose-6 phosphate from the cytoplasm into the lumen of the endoplasmic reticulum, thereby playing a key role in gl...
A. Skakic, K. Klaassen, M. Andjelkovic et al.· The Scientist· 0 citations
Related blog posts
MIT News · Artificial Intelligence· news.mit.eduNov 9, 2026
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.